• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者健康相关生活质量下降的轨迹分类:一项初步研究。

Trajectory classes of decline in health-related quality of life in Parkinson's disease: a pilot study.

机构信息

Institute of Clinical Psychology and Psychotherapy, Technische Universitaet Dresden, Dresden, Germany.

出版信息

Value Health. 2011 Mar-Apr;14(2):329-38. doi: 10.1016/j.jval.2010.10.005.

DOI:10.1016/j.jval.2010.10.005
PMID:21402301
Abstract

OBJECTIVE

To analyze the change in health-related quality-of-life (HRQoL) in patients with Parkinson's disease (PD) and to identify different classes of HRQoL decline.

METHODS

A longitudinal cohort study was performed to assess clinical parameters (unified PD rating scale, Beck Depression Inventory) and HRQoL data (EuroQol, Parkinson's Disease Questionnaire [PDQ]-39) at baseline, 3, 6, 12, 24, and 36 months. A total of 145 patients with PD were consecutively recruited in the county of Northern Hessia, Germany, between January and June 2000. A latent growth mixture model was applied to analyse the heterogeneity in HRQoL trajectories.

RESULTS

We successfully applied latent mixture growth modeling in order to identify different classes of HRQoL trajectories in PD. Three growth models were developed and each resulted in a four-class model of distinct patterns using the generic EuroQol instruments' outcomes (EuroQol-5 Dimensions and visual analogue scale) and the disease-specific PDQ-39. The four classes were defined by individual trajectory characteristics. Classes one and two represented trajectories with moderate declines over 36 months, but with different initial intercepts. Class three consisted mainly of patients who passed away during the observation period and therefore had a large HRQoL decline. Class four was characterized by a low level of HRQoL at baseline and a significant subsequent decline.

CONCLUSIONS

The findings provide a more elaborate understanding of the variability in HRQoL reduction in PD over time. The classification of different HRQoL subgroups may help to explain the response of PD patients to the natural history of the disease. Future research will enable the identification of HRQoL responder subgroups on different treatment regimens.

摘要

目的

分析帕金森病(PD)患者健康相关生活质量(HRQoL)的变化,并确定不同类别的 HRQoL 下降。

方法

进行了一项纵向队列研究,以评估基线时、3、6、12、24 和 36 个月的临床参数(统一 PD 评分量表、贝克抑郁量表)和 HRQoL 数据(EuroQol、帕金森病问卷[PDQ]-39)。2000 年 1 月至 6 月期间,德国黑森州北部县连续招募了 145 名 PD 患者。应用潜在增长混合模型分析 HRQoL 轨迹的异质性。

结果

我们成功地应用了潜在混合增长模型,以确定 PD 中不同的 HRQoL 轨迹类别。使用通用 EuroQol 仪器的结果(EuroQol-5 维度和视觉模拟量表)和疾病特异性 PDQ-39 开发了三个增长模型,每个模型都产生了四个类别的模型,具有不同的模式。四个类别的定义是基于个体轨迹特征。第 1 类和第 2 类代表在 36 个月内有中度下降的轨迹,但初始截距不同。第 3 类主要由在观察期间去世的患者组成,因此 HRQoL 下降幅度较大。第 4 类的特点是基线时 HRQoL 水平较低,随后显著下降。

结论

研究结果提供了对 PD 中随时间推移的 HRQoL 降低变异性的更详细理解。不同 HRQoL 亚组的分类可能有助于解释 PD 患者对疾病自然史的反应。未来的研究将能够确定不同治疗方案的 HRQoL 反应亚组。

相似文献

1
Trajectory classes of decline in health-related quality of life in Parkinson's disease: a pilot study.帕金森病患者健康相关生活质量下降的轨迹分类:一项初步研究。
Value Health. 2011 Mar-Apr;14(2):329-38. doi: 10.1016/j.jval.2010.10.005.
2
A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease.帕金森病患者健康相关生活质量的纵向评估。
Value Health. 2009 Mar-Apr;12(2):392-6. doi: 10.1111/j.1524-4733.2008.00430.x. Epub 2008 Jul 24.
3
Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.在一项前瞻性纵向研究中评估帕金森病患者与健康相关的生活质量。
Parkinsonism Relat Disord. 2007 Mar;13(2):108-14. doi: 10.1016/j.parkreldis.2006.07.009. Epub 2006 Oct 19.
4
Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study.俄罗斯队列研究中帕金森病患者生活质量的社会和临床决定因素。
Parkinsonism Relat Disord. 2010 May;16(4):243-8. doi: 10.1016/j.parkreldis.2009.11.012. Epub 2009 Dec 21.
5
Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.普拉克索与左旋多巴治疗早期帕金森病患者:对一般生活质量和疾病特异性生活质量的影响。
Value Health. 2006 Jan-Feb;9(1):28-38. doi: 10.1111/j.1524-4733.2006.00078.x.
6
[Health-related quality of life in Parkinson's disease].[帕金森病患者的健康相关生活质量]
Medicina (B Aires). 2010;70(6):503-7.
7
The impact of comorbidity and other clinical and sociodemographic factors on health-related quality of life in Greek patients with Parkinson's disease.共病及其他临床和社会人口学因素对希腊帕金森病患者健康相关生活质量的影响。
Aging Ment Health. 2011 Sep;15(7):913-21. doi: 10.1080/13607863.2011.569477. Epub 2011 May 24.
8
The association between objectively measured physical activity, depression, cognition, and health-related quality of life in Parkinson's disease.帕金森病患者中体力活动的客观测量、抑郁、认知和健康相关生活质量之间的关联。
Parkinsonism Relat Disord. 2018 Mar;48:74-81. doi: 10.1016/j.parkreldis.2017.12.023. Epub 2017 Dec 23.
9
Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort study.帕金森病患者的健康相关生活质量及其决定因素:一项意大利队列研究的结果。
Parkinsonism Relat Disord. 2011 May;17(4):265-9. doi: 10.1016/j.parkreldis.2011.01.003. Epub 2011 Feb 9.
10
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study.近期诊断为帕金森病患者的冷漠对健康相关生活质量的影响:ANIMO 研究。
Mov Disord. 2012 Feb;27(2):211-8. doi: 10.1002/mds.23872. Epub 2011 Jul 20.

引用本文的文献

1
Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.帕金森病患者的健康相关生活质量:EuroQol (EQ-5D) 效用评分的系统评价和荟萃分析。
Qual Life Res. 2024 Jul;33(7):1781-1793. doi: 10.1007/s11136-024-03646-8. Epub 2024 Apr 6.
2
Association of caregiver strain with the trajectory of quality of life in Parkinson's disease.照料者负担与帕金森病患者生活质量轨迹的关联。
Parkinsonism Relat Disord. 2023 Mar;108:105292. doi: 10.1016/j.parkreldis.2023.105292. Epub 2023 Jan 23.
3
A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
电子版 EQ-5D-5L 在常规临床实践中的有效性和心理测量特性的初步研究。
Health Qual Life Outcomes. 2021 Dec 18;19(1):266. doi: 10.1186/s12955-021-01898-3.
4
Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative.估计帕金森进展标志物倡议中的疾病演变。
Neurodegener Dis. 2018;18(4):173-190. doi: 10.1159/000488780. Epub 2018 Aug 8.
5
Heterogeneous depression trajectories in multiple sclerosis patients.多发性硬化症患者的异质抑郁轨迹。
Mult Scler Relat Disord. 2016 Sep;9:163-9. doi: 10.1016/j.msard.2016.08.004. Epub 2016 Aug 5.
6
Economic evaluation of ropinirole prolonged release for treatment of Parkinson's disease in the Netherlands.荷兰罗匹尼罗缓释剂治疗帕金森病的经济学评估。
Drugs Aging. 2014 Mar;31(3):193-201. doi: 10.1007/s40266-013-0150-4.